lenvatinib in advanced dtc
Published 8 years ago • 2.2K plays • Length 8:28Download video MP4
Download video MP3
Similar videos
-
6:53
sequencing in dtc: lenvatinib and sorafenib
-
0:59
dr. martins on managing toxicities associated with lenvatinib in dtc
-
6:42
the role of lenvatinib in advanced rcc
-
1:28
dr. wirth on the use of lenvatinib in hypertensive patients with thyroid cancer
-
7:37
lenvatinib as up-front therapy for unresectable hcc
-
1:17
dr. marcia brose discusses lenvatinib as a new option in dtc
-
1:39
dr. bastholt on lenvatinib in thyroid cancer
-
6:47
lenvatinib: new kid on the block
-
1:46
dr. bible on impact of lenvatinib on treatment landscape of dtc
-
1:59
dr. cohen on lenvatinib in first- or second-line thyroid cancer
-
1:10
dr. marcia brose on lenvatinib in differentiated thyroid cancer
-
2:54
lenvima (lenvatinib)- thyroid cancer (dtc)
-
4:21
tki dose adjustment in advanced dtc
-
4:27
lenvatinib in renal cell carcinoma
-
1:22
dr. cheng on phase iii findings of lenvatinib in hcc
-
6:51
hcc: use of lenvatinib and sorafenib
-
5:59
frontline lenvatinib vs sorafenib in hcc
-
2:56
dr. finn on role of lenvatinib in hcc treatment paradigm
-
2:47
dr. brose discusses lenvatinib and sorafenib in differentiated thyroid cancer